Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition
  • 1.1.2 Specifications
• 1.2 Market Segment
  • 1.2.1 by Type
    • 1.2.1.1 Live Attenuated Vaccines
    • 1.2.1.2 Killed/Inactivated Vaccines
    • 1.2.1.3 Recombinant Vaccines
    • 1.2.1.4 Others
  • 1.2.2 by Application
    • 1.2.2.1 Polio
    • 1.2.2.2 Rabies
    • 1.2.2.3 Rotavirus
    • 1.2.2.4 Cholera
    • 1.2.2.5 HIV
    • 1.2.2.6 Respiratory Infections
    • 1.2.2.7 Influenza
    • 1.2.2.8 Tuberculosis
    • 1.2.2.9 Others
  • 1.2.3 by Regions

2 Industry Chain

• 2.1 Industry Chain Structure
• 2.2 Upstream
• 2.3 Market
  • 2.3.1 SWOT
  • 2.3.2 Dynamics

3 Environmental Analysis

• 3.1 Policy
• 3.2 Economic
• 3.3 Technology
• 3.4 Market Entry

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Live Attenuated Vaccines Market, 2013-2018
  • 4.1.2 Killed/Inactivated Vaccines Market, 2013-2018
  • 4.1.3 Recombinant Vaccines Market, 2013-2018
  • 4.1.4 Others Market, 2013-2018
• 4.2 Market Forecast
  • 4.2.1 Live Attenuated Vaccines Market Forecast, 2019-2024
  • 4.2.2 Killed/Inactivated Vaccines Market Forecast, 2019-2024
  • 4.2.3 Recombinant Vaccines Market Forecast, 2019-2024
  • 4.2.4 Others Market Forecast, 2019-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Polio Market, 2013-2018
  • 5.1.2 Rabies Market, 2013-2018
  • 5.1.3 Rotavirus Market, 2013-2018
  • 5.1.4 Cholera Market, 2013-2018
  • 5.1.5 HIV Market, 2013-2018
  • 5.1.6 Respiratory Infections Market, 2013-2018
  • 5.1.7 Influenza Market, 2013-2018
  • 5.1.8 Tuberculosis Market, 2013-2018
  • 5.1.9 Others Market, 2013-2018
• 5.2 Market Forecast
  • 5.2.1 Polio Market Forecast, 2019-2024
  • 5.2.2 Rabies Market Forecast, 2019-2024
  • 5.2.3 Rotavirus Market Forecast, 2019-2024
  • 5.2.4 Cholera Market Forecast, 2019-2024
  • 5.2.5 HIV Market Forecast, 2019-2024
  • 5.2.6 Respiratory Infections Market Forecast, 2019-2024
  • 5.2.7 Influenza Market Forecast, 2019-2024
  • 5.2.8 Tuberculosis Market Forecast, 2019-2024
  • 5.2.9 Others Market Forecast, 2019-2024

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018
    • 6.1.1.2 Asia-Pacific Market by Type
    • 6.1.1.3 Asia-Pacific Market by Application
  • 6.1.2 North America
    • 6.1.2.1 North America Market, 2012-2018
    • 6.1.2.2 North America Market by Type
    • 6.1.2.3 North America Market by Application
  • 6.1.3 Europe
    • 6.1.3.1 Europe Market, 2012-2018
    • 6.1.3.2 Europe Market by Type
    • 6.1.3.3 Europe Market by Application
  • 6.1.4 South America
    • 6.1.4.1 South America Market, 2012-2018
    • 6.1.4.2 South America Market by Type
    • 6.1.4.3 South America Market by Application
  • 6.1.5 Middle East & Africa
    • 6.1.5.1 Middle East & Africa Market, 2012-2018
    • 6.1.5.2 Middle East & Africa Market by Type
    • 6.1.5.3 Middle East & Africa Market by Application
• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2019-2024
  • 6.2.2 North America Market Forecast, 2019-2024
  • 6.2.3 Europe Market Forecast, 2019-2024
  • 6.2.4 South America Market Forecast, 2019-2024
  • 6.2.5 Middle East & Africa Market Forecast, 2019-2024

7 Market Competitive

• 7.1 Global Market by Vendors
• 7.2 Market Concentration
• 7.3 Price & Factors
• 7.4 Marketing Channel

8 Major Vendors

• 8.1 GlaxoSmithKline Plc.
• 8.2 PaxVax Corporation
• 8.3 Pfizer Inc
• 8.4 Merial, Inc.
• 8.5 Merck Sharp & Dohme Corp
• 8.6 VALNEVA Canada Inc.
• 8.7 QUíMICA SUIZA S.A
• 8.8 Immunitor, Inc
• 8.9 Aventis (Sanofi S.A.)
• 8.10 Serum Institute of India Pvt. Ltd
• 8.11 Swiss Serum and Vaccine Institute Berne
• 8.12 Bull Bio - NCIPD Ltd.
• 8.13 Vaxart, Inc.
• 8.14 Shantha Biotechnics
• 8.15 Crucell (Janssen Global Services, LLC)

9 Conclusion

Summary
The global Oral Vaccines market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
GlaxoSmithKline Plc.
PaxVax Corporation
Pfizer Inc
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUíMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa